J. A. Coppell, P. G. Richardson, R. Soiffer, P. L. Martin, N. A. Kernan et al., Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome, Biol Blood Marrow Transplant, vol.16, pp.157-168, 2010.

H. M. Shulman, G. B. Mcdonald, D. Matthews, K. C. Doney, K. J. Kopecky et al., An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation, Saral R: Venoocclusive disease of the liver following bone marrow transplantation, vol.79, pp.778-783, 1980.

G. B. Mcdonald, P. Sharma, D. E. Matthews, H. M. Shulman, and E. D. Thomas, Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors, Hepatology, vol.4, pp.116-122, 1984.

E. Carreras, M. Díaz-beyá, L. Rosiñol, C. Martínez, F. Fernández-avilés et al., The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade, Biol Blood Marrow Transplant, vol.17, pp.1713-1720, 2011.

D. Valla and D. Cazals-hatem, Sinusoidal obstruction syndrome, Clin Res Hepatol Gastroenterol, vol.40, pp.378-385, 2016.

L. Viganò, L. Capussotti, D. Rosa, G. , D. Saussure et al., Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival, Ann Surg, vol.258, pp.731-740, 2013.

S. Kumar, L. D. Deleve, P. S. Kamath, and A. Tefferi, Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation, Mayo Clin Proc, vol.78, pp.589-598, 2003.

M. Mohty, F. Malard, M. Abecassis, E. Aerts, A. S. Alaskar et al., Sinusoidal obstruction syndrome/venoocclusive disease: current situation and perspectives: a position statement from the European Society for Blood and Marrow Transplantation (EBMT), Bone Marrow Transplant, vol.50, pp.781-789, 2015.

J. R. Wingard, C. S. Niehaus, D. E. Peterson, R. J. Jones, S. Piantadosi et al., Oral mucositis after bone marrow transplantation: a marker of treatment toxicity and predictor of hepatic veno-occlusive disease. Oral Surg Oral Med Oral Pathol, vol.72, pp.419-424, 1991.

C. Q. Fan and J. M. Crawford, Sinusoidal obstruction syndrome (hepatic veno-occlusive disease), J Clin Exp Hepatol, vol.4, pp.332-346, 2014.

P. G. Richardson, S. A. Grupp, A. Pagliuca, A. Krishnan, V. T. Ho et al., Defibrotide for the treatment of hepatic venoocclusive disease/sinusoidal obstruction syndrome with multiorgan failure, Int J Hematol Oncol, vol.6, pp.75-93, 2017.

E. Carreras and M. Diaz-ricart, The role of the endothelium in the shortterm complications of hematopoietic SCT, Bone Marrow Transplant, vol.46, pp.1495-1502, 2011.

L. D. Deleve, H. M. Shulman, and G. B. Mcdonald, Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease)

, Semin Liver Dis, vol.22, pp.27-42, 2002.

S. M. Robinson, J. Mann, A. Vasilaki, J. Mathers, A. D. Burt et al., Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model, J Hepatol, vol.59, pp.318-326, 2013.

C. Marzano, D. Cazals-hatem, P. Rautou, and D. Valla, The significance of nonobstructive sinusoidal dilatation of the liver: impaired portal perfusion or inflammatory reaction syndrome, Hepatology, vol.62, pp.956-963, 2015.

A. Vion, P. Rautou, F. Durand, C. M. Boulanger, and D. C. Valla, Interplay of inflammation and endothelial dysfunction in bone marrow transplantation: focus on hepatic veno-occlusive disease, Semin Thromb Hemost, vol.41, pp.629-643, 2015.

Y. Sato, Y. Asada, S. Hara, K. Marutsuka, K. Tamura et al., Hepatic stellate cells (Ito cells) in veno-occlusive disease of the liver after allogeneic bone marrow transplantation. Histopathology, vol.34, pp.66-70, 1999.

W. Nürnberger, I. Michelmann, S. Burdach, and U. Göbel, Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplantrelated complications, Ann Hematol, vol.76, pp.61-65, 1998.

C. Salat, E. Holler, H. J. Kolb, R. Pihusch, B. Reinhardt et al., Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease, Bone Marrow Transplant, vol.19, pp.909-914, 1997.

S. Y. Mahgerefteh, J. Sosna, N. Bogot, M. Y. Shapira, O. Pappo et al., Radiologic imaging and intervention for gastrointestinal and hepatic complications of hematopoietic stem cell transplantation, Radiology, vol.258, pp.660-671, 2011.

N. Lassau, J. Leclère, A. Auperin, J. H. Bourhis, O. Hartmann et al., Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients, Radiology, vol.204, pp.545-552, 1997.

B. P. Brown, M. Abu-yousef, R. Farner, D. Labrecque, and R. Gingrich, Doppler sonography: a noninvasive method for evaluation of hepatic venocclusive disease, AJR Am J Roentgenol, vol.154, pp.721-724, 1990.

S. M. Erturk, K. J. Mortelé, C. A. Binkert, J. N. Glickman, M. Oliva et al., CT features of hepatic venoocclusive disease and hepatic graft-versus-host disease in patients after hematopoietic stem cell transplantation, AJR Am J Roentgenol, vol.186, pp.1497-1501, 2006.

J. Ward, J. A. Guthrie, M. B. Sheridan, S. Boyes, J. T. Smith et al., Sinusoidal obstructive syndrome diagnosed with superparamagnetic iron oxide-enhanced magnetic resonance imaging in patients with chemotherapy-treated colorectal liver metastases, J Clin Oncol, vol.26, pp.4304-4310, 2008.

T. R. O'rourke, F. Welsh, P. P. Tekkis, N. Lyle, A. Mustajab et al., Accuracy of liver-specific magnetic resonance imaging as a predictor of chemotherapy-associated hepatic cellular injury prior to liver resection, Eur J Surg Oncol, vol.35, pp.1085-1091, 2009.

M. Gauthé, L. Bozec, and P. Bedossa, Diagnosis of sinusoidal obstruction syndrome by positron emission tomography/computed tomography: report of two cases treated by defibrotide, Hepatology, vol.60, pp.1789-1791, 2014.

S. H. Park, S. S. Lee, J. Sung, N. K. Kim, H. J. Kim et al., Noninvasive assessment of hepatic sinusoidal obstructive syndrome using acoustic radiation force impulse elastography imaging: a proof-of-concept study in rat models, Eur Radiol, vol.28, pp.2096-2106, 2018.

J. Auberger, I. Graziadei, J. Clausen, W. Vogel, and D. Nachbaur, Noninvasive transient elastography for the prediction of liver toxicity following hematopoietic SCT, Bone Marrow Transplant, vol.48, pp.159-160, 2013.

E. Carreras, A. Grañena, M. Navasa, M. Bruguera, V. Marco et al., Transjugular liver biopsy in BMT, vol.11, pp.21-26, 1993.

H. M. Shulman, T. Gooley, M. D. Dudley, T. Kofler, R. Feldman et al., Diagnostic yield of transjugular liver biopsy samples to evaluate for infectious etiology of liver dysfunction in bone marrow transplant recipients, Cardiovasc Intervent Radiol, vol.59, pp.471-475, 1995.

O. Ahmed, T. J. Ward, M. P. Lungren, A. Mohammed, M. A. Hofmann et al., Assessing the risk of hemorrhagic complication following transjugular liver biopsy in bone marrow transplantation recipients, J Vasc Interv Radiol, vol.27, pp.551-557, 2016.

, Carreras E: How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation, Br J Haematol, vol.168, pp.481-491, 2015.

S. J. Vukelja, W. J. Baker, P. Jeffreys, B. A. Reeb, and T. Pick, Nonbacterial thrombotic endocarditis clinically mimicking veno-occlusive disease of the liver complicating autologous bone marrow transplantation, Am J Clin Oncol, vol.15, pp.500-502, 1992.

A. Srivastava, B. Poonkuzhali, R. V. Shaji, B. George, V. Mathews et al., Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation, Blood, vol.104, pp.1574-1577, 2004.

A. R. Kallianpur, L. D. Hall, M. Yadav, D. W. Byrne, T. Speroff et al., The hemochromatosis C282Y allele: a risk factor for hepatic veno-occlusive disease after hematopoietic stem cell transplantation, Bone Marrow Transplant, vol.35, pp.1155-1164, 2005.

C. Mellis and P. M. Bale, Familial hepatic venoocclusive disease with probable immune deficiency, J Pediatr, vol.88, pp.236-242, 1976.

T. Wang, P. Ong, T. Roscioli, S. T. Cliffe, and J. A. Church, Hepatic venoocclusive disease with immunodeficiency (VODI): first reported case in the U.S. and identification of a unique mutation in Sp110, Clin Immunol, vol.145, pp.102-107, 2012.

S. T. Cliffe, D. B. Bloch, S. Suryani, E. Kamsteeg, D. T. Avery et al., Roscioli T: Clinical, molecular, and cellular immunologic findings in patients with SP110-associated veno-occlusive disease with immunodeficiency syndrome, J Allergy Clin Immunol, vol.130, pp.735-742, 2012.

T. Roscioli, S. T. Cliffe, D. B. Bloch, C. G. Bell, G. Mullan et al., Mutations in the gene encoding the PML nuclear body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive disease, Nat Genet, vol.38, pp.620-622, 2006.

G. B. Mcdonald, M. S. Hinds, L. D. Fisher, H. G. Schoch, J. L. Wolford et al., Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients, Ann Intern Med, vol.118, pp.255-267, 1993.

L. D. Deleve, D. Valla, and G. Garcia-tsao, American Association for the Study Liver Diseases: Vascular disorders of the liver, Hepatology, vol.49, pp.1729-1764, 2009.

S. Corbacioglu, S. Cesaro, M. Faraci, D. Valteau-couanet, B. Gruhn et al., Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an openlabel, phase 3, randomised controlled trial, Lancet, vol.379, pp.1301-1309, 2012.

B. Ranchoux, S. Günther, R. Quarck, M. Chaumais, P. Dorfmüller et al., Chemotherapy-induced pulmonary hypertension: role of alkylating agents, Am J Pathol, vol.185, pp.356-371, 2015.

R. K. Tandon, B. N. Tandon, H. D. Tandon, M. L. Bhatia, S. Bhargava et al., Study of an epidemic of venoocclusive disease in India, Gut, vol.17, pp.849-855, 1976.

F. L. Dignan, R. F. Wynn, N. Hadzic, J. Karani, A. Quaglia et al., Haemato-oncology Task Force of British Committee for Standards in Haematology; British Society for Blood and Marrow Transplantation: BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation, Br J Haematol, vol.163, pp.444-457, 2013.

T. Ruutu, E. Juvonen, M. Remberger, K. Remes, L. Volin et al., Nordic Group for Blood and Marrow Transplantation: Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study, Biol Blood Marrow Transplant, vol.20, pp.135-138, 2014.

T. Ruutu, B. Eriksson, K. Remes, E. Juvonen, L. Volin et al., Nordic Bone Marrow Transplantation Group: Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation, Blood, vol.100, 2002.

P. G. Richardson, M. L. Riches, N. A. Kernan, J. A. Brochstein, S. Mineishi et al., Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure, Blood, vol.127, pp.1656-1665, 2016.

A. Beihany, A. , A. Omar, H. Sahovic, E. Chaudhri et al., Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course of methylprednisolone, Bone Marrow Transplant, vol.41, pp.287-291, 2008.

E. Carreras, H. Bertz, W. Arcese, J. P. Vernant, J. F. Tomás et al.,

, European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party: Incidence and outcome of hepatic venoocclusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation, Blood, vol.92, pp.3599-3604, 1998.

L. D. Deleve, R. S. Mccuskey, X. Wang, L. Hu, M. K. Mccuskey et al., Characterization of a reproducible rat model of hepatic veno-occlusive disease, Hepatology, vol.29, pp.1779-1791, 1999.

P. Czauderna, L. Chyczewski, K. Lech, G. Langner, G. Bednarczuk et al., Experimental model of hepatic venoocclusive disease (VOD) caused by dactinomycin: preliminary report about hepatoprotective effect of amifostine, Med Sci Monit, vol.6, pp.446-453, 2000.

G. Simonneau, D. Montani, D. S. Celermajer, C. P. Denton, M. A. Gatzoulis et al., Haemodynamic definitions and updated clinical classification of pulmonary hypertension, Eur Respir J, vol.53, p.1801913, 2019.

J. Höra,

. German, Frankf Z Pathol, vol.47, pp.100-108, 1934.

D. Heath, N. Segel, and J. Bishop, Pulmonary veno-occlusive disease, Circulation, vol.34, pp.242-248, 1966.

M. Eyries, D. Montani, B. Girerd, C. Perret, A. Leroy et al., Soubrier F: EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension, Nat Genet, vol.46, pp.65-69, 2014.

D. H. Best, K. L. Sumner, E. D. Austin, W. K. Chung, L. M. Brown et al., CG: EIF2AK4 mutations in pulmonary capillary hemangiomatosis, Chest, vol.145, pp.231-236, 2014.

D. Montani, E. M. Lau, P. Dorfmüller, B. Girerd, X. Jaïs et al., Pulmonary veno-occlusive disease, Eur Respir J, vol.47, pp.1518-1534, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02561102

F. Perros, S. Günther, B. Ranchoux, L. Godinas, F. Antigny et al., Mitomycin-induced pulmonary veno-occlusive disease: evidence from human disease and animal models, Circulation, vol.132, pp.834-847, 2015.

V. B. Pai and M. C. Nahata, Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention, Drug Saf, vol.22, pp.263-302, 2000.

D. Montani, E. M. Lau, A. Descatha, X. Jaïs, L. Savale et al., Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease, Eur Respir J, vol.46, pp.1721-1731, 2015.

M. D. Mcgoon, R. L. Benza, P. Escribano-subias, X. Jiang, D. P. Miller et al., Pulmonary arterial hypertension: epidemiology and registries, J Am Coll Cardiol, vol.62, pp.51-59, 2013.

E. K. Larkin, J. H. Newman, E. D. Austin, A. R. Hemnes, L. Wheeler et al., Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.186, pp.892-896, 2012.

E. Bal, S. Ilgin, O. Atli, B. Ergun, and B. Sirmagul, The effects of gender difference on monocrotaline-induced pulmonary hypertension in rats, Hum Exp Toxicol, vol.32, pp.766-774, 2013.

F. Perros, S. Cohen-kaminsky, N. Gambaryan, B. Girerd, N. Raymond et al., Cytotoxic cells and granulysin in pulmonary arterial hypertension and pulmonary veno-occlusive disease, Am J Respir Crit Care Med, vol.187, pp.189-196, 2013.

E. Marcos, E. Fadel, O. Sanchez, M. Humbert, P. Dartevelle et al., Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension, Circ Res, vol.94, pp.1263-1270, 2004.

R. Kradin, O. Matsubara, and E. J. Mark, Endothelial nitric oxide synthase expression in pulmonary capillary hemangiomatosis, Exp Mol Pathol, vol.79, pp.194-197, 2005.

E. J. Nossent, F. Antigny, D. Montani, H. J. Bogaard, M. R. Ghigna et al., Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease, J Heart Lung Transplant, vol.37, pp.647-655, 2018.

C. A. Wagenvoort and N. Wagenvoort, The pathology of pulmonary venoocclusive disease, Virchows Arch A Pathol Anat Histol, vol.364, pp.69-79, 1974.

D. E. Schraufnagel, M. Sekosan, T. Mcgee, and M. B. Thakkar, Human alveolar capillaries undergo angiogenesis in pulmonary venoocclusive disease, Eur Respir J, vol.9, pp.346-350, 1996.

D. Montani, L. Achouh, P. Dorfmüller, L. Pavec, J. Sztrymf et al., Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology, Medicine, vol.87, pp.220-233, 2008.

D. Montani, B. Girerd, X. Jaïs, M. Levy, D. Amar et al., Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study, Lancet Respir Med, vol.5, pp.125-134, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01436297

A. Resten, S. Maitre, M. Humbert, A. Rabiller, O. Sitbon et al., Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease, AJR Am J Roentgenol, vol.183, pp.65-70, 2004.

A. Rabiller, X. Jaïs, A. Hamid, A. Resten, F. Parent et al., Occult alveolar haemorrhage in pulmonary veno-occlusive disease, Eur Respir J, vol.27, pp.108-113, 2006.

E. Sourla, A. Paspala, A. Boutou, P. Kontou, I. Stanopoulos et al., A case of pulmonary veno-occlusive disease: diagnostic dilemmas and therapeutic challenges, Ther Adv Respir Dis, vol.7, pp.119-123, 2013.

B. Girerd, D. Montani, X. Jaïs, M. Eyries, A. Yaici et al., Genetic counselling in a national referral centre for pulmonary hypertension, Eur Respir J, vol.47, pp.541-552, 2016.

M. J. Overbeek, M. C. Vonk, A. Boonstra, A. E. Voskuyl, A. Vonk-noordegraaf et al., Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy, Eur Respir J, vol.34, pp.371-379, 2009.

P. Dorfmüller, M. Humbert, F. Perros, O. Sanchez, G. Simonneau et al., Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases, Hum Pathol, vol.38, pp.893-902, 2007.

D. S. Celermajer, K. E. Sorensen, D. Georgakopoulos, C. Bull, O. Thomas et al., Cigarette smoking is associated with doserelated and potentially reversible impairment of endotheliumdependent dilation in healthy young adults, Circulation, vol.88, pp.2149-2155, 1993.

J. L. Wright and A. Churg, Effect of long-term cigarette smoke exposure on pulmonary vascular structure and function in the guinea pig, Exp Lung Res, vol.17, pp.997-1009, 1991.

N. Weissmann, F. Grimminger, and W. Seeger, Smoking: is it a risk factor for pulmonary vascular diseases, Pulm Circ, vol.2, pp.395-396, 2012.

J. A. Foster-nora and R. Siden, Amifostine for protection from antineoplastic drug toxicity, Am J Health Syst Pharm, vol.54, pp.787-800, 1997.

B. W. Holcomb, J. E. Loyd, E. W. Ely, J. Johnson, and I. M. Robbins, Pulmonary veno-occlusive disease: a case series and new observations, Chest, vol.118, pp.1671-1679, 2000.

D. W. Wilson, H. J. Segall, L. C. Pan, and S. K. Dunston, Progressive inflammatory and structural changes in the pulmonary vasculature of monocrotaline-treated rats, Microvasc Res, vol.38, pp.57-80, 1989.

B. O. Meyrick and L. M. Reid, Crotalaria-induced pulmonary hypertension: uptake of 3H-thymidine by the cells of the pulmonary circulation and alveolar walls, Am J Pathol, vol.106, pp.84-94, 1982.

F. Gagnadoux, F. Capron, and B. Lebeau, Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma, Lung Cancer, vol.36, pp.213-215, 2002.

G. L. Swift, A. Gibbs, I. A. Campbell, C. A. Wagenvoort, and D. Tuthill, Pulmonary veno-occlusive disease and Hodgkin's lymphoma, Eur Respir J, vol.6, pp.596-598, 1993.

A. G. Rose, Pulmonary veno-occlusive disease due to bleomycin therapy for lymphoma: case reports, S Afr Med J, vol.64, pp.636-638, 1983.

C. C. Yan and R. J. Huxtable, Effects of monocrotaline, a pyrrolizidine alkaloid, on glutathione metabolism in the rat, Biochem Pharmacol, vol.51, pp.375-379, 1996.

T. Miyauchi, R. Yorikane, S. Sakai, T. Sakurai, M. Okada et al., Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension, Circ Res, vol.73, pp.887-897, 1993.

J. F. Reindel and R. A. Roth, The effects of monocrotaline pyrrole on cultured bovine pulmonary artery endothelial and smooth muscle cells, Am J Pathol, vol.138, pp.707-719, 1991.

M. R. Kramer, M. Estenne, N. Berkman, M. Antoine, P. De-francquen et al., Radiation-induced pulmonary venoocclusive disease, Chest, vol.104, pp.1282-1284, 1993.

I. Kim, H. Egawa, Y. Marui, S. Kaihara, H. Haga et al., A successful liver transplantation for refractory hepatic veno-occlusive disease originating from cord blood transplantation, Am J Transplant, vol.2, pp.796-800, 2002.

B. Zethelius, L. Berglund, J. Sundström, E. Ingelsson, S. Basu et al., Use of multiple biomarkers to improve the prediction of death from cardiovascular causes, N Engl J Med, vol.358, pp.2107-2116, 2008.